Liposomes decorated with P-selectin glycoprotein ligand-1, which targets tumor-associated endothelial cells, can deliver bortezomib (BTZ) and agents that disrupt the bone marrow microenvironment to the tumor area in MM. The gene discussed is SELPLG; the disease is neoplasm.